Artigo Acesso aberto Revisado por pares

The classification of depression.

1983; Wiley; Volume: 15; Issue: S2 Linguagem: Inglês

10.1111/j.1365-2125.1983.tb05860.x

ISSN

1365-2125

Autores

E. S. Paykel,

Tópico(s)

Schizophrenia research and treatment

Resumo

British Journal of Clinical PharmacologyVolume 15, Issue S2 p. 155S-159S Free Access The classification of depression. ES Paykel, ES PaykelSearch for more papers by this author ES Paykel, ES PaykelSearch for more papers by this author First published: April 1983 https://doi.org/10.1111/j.1365-2125.1983.tb05860.xCitations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Reference ANDREASEN, N.C. (1982). Concepts, diagnosis and classification. In: Handbook of Affective Disorders, ed. E.S. Paykel, pp. 24– 44. Edinburgh: Churchill Livingstone.. ANGST, J. (1966). The Aetiology and Nosology of Endogenous Depressive Psychoses: A Genetic, Sociological and Clinical Study. Berlin: Springer-Verlag.. GERSH, F.S. & FOWLES, D.C. (1979). Neurotic depression: the concept of anxious depression. In: Psychobiology of Depressive Disorders, pp. 81– 104. HOLLISTER, L.E., OVERALL, J.E., JOHNSON, M.R., SHELTON, J., KIMBELL, I. & BRUNSE, A. (1966). Amitriptyline alone and combined with perphenazine in newly admitted depressed patients. J. Nerv. Ment. Dis., 142, 460– 469. HOLLISTER, L.E., OVERALL, J.E., SHELTON, J., PENNINGTON, V., KIMBELL, I. & JOHNSON, M. (1967). Drug therapy of depression amitriptyline, perphenazine and their combination in different syndromes. Arch. Gen. Psychiat., 17, 486– 493. JOHNSTONE, E.C., CUNNINGHAM OWENS, D.G., FRITH, C.D., MCPHERSON, K., DOWIE, C., RILEY, G. & GOLD, A. (1980). Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol. Med., 10, 321– 328. KATZ, M.M., ROBINS, E., CROUGHAN, J., SECUNDA, S. & SWANN, A. (1982). Behavioural measurement and drug response characteristics of unipolar and bipolar depression. Psychol. Med., 12, 25– 36. KENDELL, R.E. (1968). The classification of depressive illnesses.. Maudsley Monogr., No. 18 London: Oxford University Press.. MARKS, I.M., STERN, R.S., MAWSON, D., COBB, J. & MCDONALD, R. (1980). Clomipramine and exposure for obsessive-compulsive rituals, I. Br. J. Psychiat., 136, 1– 25. OVERALL, J.E., HOLLISTER, L.E., JOHNSON, M. & PENNINGTON, V. (1966). Nosology of depression and differential response to drugs. J. Am. Med. Assoc., 195, 946– 948. OVERALL, J.E. & RHOADES, H.M. (1982). Refinement of phenomenological classification in clinical psychopharmacology research. Psychopharmacol., 11, 24– 30. PAYKEL, E.S. (1971). Classification of depressed patients: a cluster analysis derived grouping. Br. J. Psychiat., 118, 275– 288. PAYKEL, E.S. (1972). Depressive typologies and response to amitriptyline. Br. J. Psychiat., 120, 147– 156. PAYKEL, E.S. (1979). Predictors of treatment response. In: Psychopharmacology of Affective Disorders, pp. 193– 220. Oxford: Oxford University Press.. E.S. PAYKEL, ed. (1982). Life events and early environment. In: Handbook of Affective Disorders, pp. 146– 161. Edinburgh: Churchill Livingstone.. PAYKEL, E.S. & HENDERSON, A.L. (1977). Application of a cluster analysis in the classification of depression: a replication study. Neuropsychobiol., 3, 111– 119. PAYKEL, E.S., PARKER, R.R., PENROSE, R.J.J. & RASSABY, E.R. (1979). Depressive classification and orediction of response to phenelzine. Br. J. Psychiat., 134, 572– 581. PAYKEL, E.S., PRUSOFF, B.A. & KLERMAN, G.L. (1971). The endogenous-neurotic continuum in depression: rater independence and factor distributions. J. Psychiat. Res., 8, 73– 90. PAYKEL, E.S., ROWAN, P.R., RAO, B.M. & BHAT, A. Atypical depression: nosology and response to antidepressants. In: Treatment of Depression: Old Controversies and New Approaches, ed. New York: Raven Press, in press.. PERRIS, C. (1966). A study of bipolar and unipolar recurrent depressive psychoses. Acta Psychiat. Scand., 42 (Suppl. 194). PERRIS, C. (1982). The distinction between bipolar and unipolar affective disorders. In: Handbook of Affective Disorders, ed. E.S. Paykel, pp. 45– 58. Edinburgh: Churchill Livingstone.. POLLITT, J. (1965). Depression and its Treatment. London: Heinemann.. PRUSOFF, B.A. & PAYKEL, E.S. (1977). Typological prediction of responses to amitriptyline: a replication study. Int. Pharmacopsychiat., 12, 153– 159. QUITKIN, F.M., LIEBOWITZ, M. & KLEIN, D.F. Comparison of monoamine oxidase inhibitors and tricyclic antidepressants in the treatment of depression. In: Treatment of Depression: Old Controversies and New Approaches. New York: Raven Press, in press.. RAVARIS, C.L., ROBINSON, D.S., IVES, J.O., NIES, A. & BARTLETT, D. (1980). Phenelzine and amitriptyline in the treatment of depression. Arch. Gen. Psychiat., 37, 1075– 1080. ROBINSON, D.S., NIES, A., RAVARIS, C.L., IVES, J.O. & LAMBORN, K.R. (1974). Treatment response to MAO inhibitors: relation to depressive typology and blood platelet MAO inhibition. In: Classification and Prediction of Outcome of Depression, pp. 259– 267. Stuttgart: Schattauer-Verlag.. ROSENTHAL, S.H. & KLERMAN, G.L. (1966). Content and consistency in the endogenous depressive pattern. Br. J. Psychiat., 112, 471– 484. ROSENTHAL, S.H. & GUDEMAN, J.E. (1967a). The endogenous depressive pattern: an empirical investigation. Arch. Gen. Psychiat., 16, 241– 249. ROSENTHAL, S.H. & GUDEMAN, J.E. (1967b). The selfpitying constellation in depression. Br. J. Psychiat., 113, 485– 489. ROWAN, P.R., PAYKEL, E.S. & PARKER, R.R. (1982). Phenelzine and amitriptyline: effects on symptoms of neurotic depression. Br. J. Psychiat., 140, 475– 483. SHEEHAN, D.V., BALLENGER, J. & JACOBSEN, G. (1980). Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch. Gen. Psychiat., 37, 51– 59. TYRER, P. (1976). Towards rational therapy with monoamine oxidase inhibitors. Br. J. Psychiat., 128, 354– 360. VAN PRAAG, H.M., ULEMAN, A.M. & SPITZ, J.C. (1965). The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiat. Neurol. Neurosurg., 68, 329– 346. WEST, E.D. & DALLY, P.J. (1959). Effects of iproniazid in depressive syndromes. Br. Med. J., 1, 1491– 1499. ZITRIN, C.M., KLEIN, D.F. & WOERNER, M.G. (1980). Treatment of agoraphobia with group exposure in vivo and imipramine. Arch. Gen. Psychiat., 37, 63– 72. Citing Literature Volume15, IssueS2April 1983Pages 155S-159S ReferencesRelatedInformation

Referência(s)